{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:07:13Z","timestamp":1768277233808,"version":"3.49.0"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,12]],"date-time":"2002-01-12T00:00:00Z","timestamp":1010793600000},"content-version":"vor","delay-in-days":286,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:p>We have treated 10 patients with relapsed or refractory T\u2010cell malignancies using gemcitabine. The drug was administered intravenously over 30\u2003min at a dose of 1200\u2003mg\/m<jats:sup>2<\/jats:sup> on d\u20031, 8 and 15 of each 28\u2010d cycle. The mean age of the patients was 62\u2003years and the mean number of administered cycles was three. Of the 10 patients, two achieved a complete response and four a partial response, for an overall response rate of 60% (95% confidence interval 20\u201335%). The toxicity of chemotherapy was mild and manageable in all patients. These encouraging results warrant further investigation of gemcitabine either as a single agent or in combination regimens as early salvage treatment for patients with refractory T\u2010cell haematological neoplasms.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2001.02743.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:33:10Z","timestamp":1047364390000},"page":"185-187","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Treatment of refractory T\u2010cell malignancies using gemcitabine"],"prefix":"10.1111","volume":"113","author":[{"given":"Sabah","family":"Sallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim Y.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,12]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(95)00067-4"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.1988.6.10.1584","article-title":"T\u2010cell lymphomas: immunologic, histologic, clinical and therapeutic analysis of 63 cases","volume":"6","author":"Coiffier B.","year":"1988","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008377724139"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood.V67.6.1578.1578","article-title":"Clinical and phenotypic diversity of T\u2010cell lymphomas","volume":"67","author":"Horning S.J.","year":"1986","journal-title":"Blood"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357908409040316"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050368"},{"key":"e_1_2_5_8_1","first-page":"15","article-title":"Activity of gemcitabine in patients with advanced pancreatic carcinoma, a review","volume":"78","author":"Moore M.","year":"1996","journal-title":"British Journal of Cancer"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.7.2667"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<971::AID-CNCR2820650425>3.0.CO;2-B"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01139.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2615"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2603"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02743.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2001.02743.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2001.02743.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T09:54:36Z","timestamp":1697536476000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2001.02743.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1046\/j.1365-2141.2001.02743.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2001.02743.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]},"assertion":[{"value":"2002-01-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}